CheckMyRecalls

Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60…

Slate Run Pharmaceuticals recalls Cinacalcet Hydrochloride Tablets 60 mg and 1 more

Published
26 Mar 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04

Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-007-04

Brand / company
Slate Run Pharmaceuticals
Codes / lots
Lot # 109797, Exp 11/2026 | Lot # 07711, Exp 07/2025; 08900, Exp 09/2026; 08899, Exp 09/2026
Distribution
Product was distributed to 8 distributors who may have further distribute the product nationwide.
Recall status
Completed

Source: U.S. Food and Drug Administration, published 26 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.